Bioharvest Sciences To Report Fourth Quarter And Full Year 2025 Financial Results On March 31, 2026

(MENAFN- Newsfile Corp) BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026

March 17, 2026 8:30 AM EDT | Source: BioHarvest Sciences Inc.

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical SynthesisTM platform, today announced that it will report its fourth quarter and full year 2025 financial results after market close on Tuesday, March 31, 2026. The Company will host a conference call and webcast at 4:30 p.m. Eastern Daylight Time to discuss the results and provide an update on business operations.

Fourth Quarter and Full Year 2025 Earnings Call

Date: Tuesday, March 31, 2026
Time: 4:30 PM Eastern Time
Webcast link:

The Earnings call webcast will be broadcast live, and attendees are encouraged to register via the webcast link at least 10 minutes prior to the call to ensure timely participation.

The webcast recording will be available for replay on the Company's website within the Investor Relations/Events & Presentations section.

About BioHarvest Sciences
BioHarvest (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit .

Forward-Looking Statements

Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. Forward-looking statements include those set forth in the Risk Factors section of the Company's Securities and Exchange Commission (SEC)'s filings which can be found within the Investor Relations section on the Company's website, or on the SEC's website at .

BioHarvest Corporate Contact:
Dave Ryan
(604) 622-1186
...

Investor Relations Contact:
Chuck Padala, Managing Director
LifeSci Advisors
...

To view the source version of this press release, please visit

Source: BioHarvest Sciences Inc.

MENAFN17032026004218003983ID1110872560